← Research library

Eight weeks of intravenous thymopentin in active rheumatoid arthritis

Study involving people · 1991

What was studied
20 people with active rheumatoid arthritis at Hanyang University, Seoul. There was no comparison group.
Main finding
Study-defined response at six to eight weeks · 11/20 responded. Two improved in functional class and nine showed mild symptom improvement. Seven were unchanged and two worsened. No remission was reported.

Reported findings and study design

Reported findings

50 mg thymopentin mixed with 10 mL saline, infused IV over 10 minutes three times weekly for eight weeks. Existing NSAIDs continued at unchanged doses. Corticosteroids and disease-modifying antirheumatic drugs were withheld during treatment.

Population or model 20 people with active rheumatoid arthritis at Hanyang University, Seoul. There was no comparison group.

Dose, route and schedule

50 mg thymopentin mixed with 10 mL saline, infused IV over 10 minutes three times weekly for eight weeks. Existing NSAIDs continued at unchanged doses. Corticosteroids and disease-modifying antirheumatic drugs were withheld during treatment.

Protocol source ↗ · Original Korean full text, including Tables 1, 3 and 5.

Results · Original Korean full text, including Tables 1, 3 and 5.
MeasureResultComparison, timing and statistics
Study-defined response at six to eight weeks11/20 responded. Two improved in functional class and nine showed mild symptom improvement. Seven were unchanged and two worsened. No remission was reported.
Follow-up and safetyOnly three still showed improvement six weeks after treatment ended. Three participants had transient adverse effects, and none stopped treatment because of them.

The response rule was specific to the study, and changes from baseline came from an uncontrolled single-center series.

Source for these results ↗ · Reviewed 2026-11-14

Study limitations and source details

Study limitations

  • The response rule was specific to the study, and changes from baseline came from an uncontrolled single-center series.

Source details

Original Korean full text, including Tables 1, 3 and 5.

Sources checked

Added to the library

Citation

Human study · design details unresolvedFull text available

D. H. Yoo, S. C. Bae, C. H. Park, S. Y. Kim. Eight weeks of intravenous thymopentin in active rheumatoid arthritis Korean Journal of Internal Medicine (Korean-language edition) 41(4), 518–524

Study source ↗ · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards